Editorial
Copyright ©2010 Baishideng.
World J Gastroenterol. Aug 21, 2010; 16(31): 3871-3877
Published online Aug 21, 2010. doi: 10.3748/wjg.v16.i31.3871
Figure 1
Figure 1 Therapeutic implication of cancer stem cells. The failure of current standard therapies in tumor eradication can be explained by assuming that colorectal cancer stem cells (CRC-SCs) are able to survive treatments leading to an only transitory clinical remission. Therapeutic strategies that specifically target the CRC-SC pool, by eliminating the self-renewing component of the tumor mass, could be more effective in eradicating the tumor and reducing the risk of relapse and metastasis.